| Antibiotics |
1 |
1 |
| Hospital |
0 |
0.97 |
| Pandemic |
0 |
0.98 |
| Severe Acute Respiratory Syndrome |
0 |
0.37 |
| COVID-19 |
0 |
0.99 |
| Acute Respiratory Distress Syndrome |
0 |
0.29 |
| Antimicrobial Resistance |
0 |
0.24 |
| Microbicides |
0 |
0.2 |
| Antimicrobial Stewardship |
0 |
0.16 |
| Grant |
0 |
0.11 |
| Antibacterial Agents |
0 |
0.09 |
| Bacteria |
0 |
0.09 |
| Sepsis |
0 |
0.09 |
| Europe |
0 |
0.06 |
| Microbiology |
0 |
0.06 |
| Microbiome |
0 |
0.04 |
| Abdomen |
0 |
0.03 |
| Antigens |
0 |
0.03 |
| Blood |
0 |
0.03 |
| Medical Technology |
0 |
0.03 |
| Polymerase Chain Reaction |
0 |
0.03 |
| Stress |
0 |
0.03 |
| Biologic Therapy |
0 |
0.02 |
| Healthcare and Medical Technology |
0 |
0.02 |